C4 Therapeutics, Inc. (CCCC)
3.53
-0.06
(-1.67%)
USD |
NASDAQ |
Jun 09, 15:37
C4 Therapeutics EPS Diluted (Quarterly) : -0.1993 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cartesian Therapeutics, Inc. | -1.459 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | 2.878 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.13M |
| Revenue (Quarterly) | 6.152M |
| Total Expenses (Quarterly) | 31.28M |
| Enterprise Value | 196.27M |
| Gross Profit Margin (Quarterly) | 70.72% |
| Profit Margin (Quarterly) | -408.5% |
| Earnings Yield | -33.55% |
| Normalized Earnings Yield | -30.62 |